HealthEquity Q3 revenue $216.1M (+20% YoY); narrows net loss; guides FY2024 ~$950-970M

HEALTHEQUITY, INC.

2023-Q3 EPS reported -$0.31 revenue$627,907,000

Revenue $216.1M (+20% YoY); net loss $1.6M vs $5.0M loss; non-GAAP diluted EPS $0.38 vs $0.35.
Adjusted EBITDA $73.4M (+20%); margin 34%; HSAs 7.7M (+23%); total accounts 14.5M (+9%).
FY2023 outlook: revenue $850-860M; Adj EBITDA $261-271M; non-GAAP EPS $1.26-$1.35.
FY2024 initial guidance: revenue ~$950-970M; Adj EBITDA margin ~33-34%; assumes ~2.25% cash yield.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

HEALTHEQUITY, INC. reported third quarter ended October 31, 2022 results: revenue $216.1 million, net income Net loss of $1.6 million, EPS Net loss per diluted share of $0.02.

Period: third quarter ended October 31, 2022
Revenue: $216.1 million
Net income: Net loss of $1.6 million
EPS: Net loss per diluted share of $0.02
Result: reported results

Exact text from the filing

Revenue of $216.1 million, an increase of 20% compared to $180.0 million in Q3 FY22. • Net loss of $1.6 million, compared to $5.0 million in Q3 FY22, with non-GAAP net income of $32.4 million, an increase of 12% compared to $28.9 million in Q3 FY22. • Net loss per diluted share of $0.02, compared to $0.06 in Q3 FY22, with non-GAAP net income per diluted share of $0.38, compared to $0.35 in Q3 FY22.

View on SEC.gov

171 earnings releases filed in the last 30 days. Browse all earnings releases →

HEALTHEQUITY, INC. filing history →

Source: SEC EDGAR

accession 0001428336-22-000031

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.